Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Caroline Porter

3PUBLICATIONS

15CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Dec 09, 2024

Additional expression of T-cell engager in clinically tested oncolytic adeno-immunotherapy redirects tumor-infiltrated, irrelevant T cells against cancer cells to enhance antitumor immunity.

Daisuke Morita, Amanda Rosewell Shaw, Greyson Biegert

|Sep 03, 2024

Chick Embryo Chorioallantoic Membrane as a Platform for Assessing the In Vivo Efficacy of Chimeric Antigen Receptor T-cell Therapy in Solid Tumors.

Allison J Nipper, Emilie A K Warren, Kershena S Liao

|Mar 29, 2023

Ultralow-dose binary oncolytic/helper-dependent adenovirus promotes antitumor activity in preclinical and clinical studies.

Daniel Wang, Caroline E Porter, Bora Lim

Pageof 1

Frequent Collaborators

3 joint publications

Masataka Suzuki

2 joint publications

Mae Woods

1 joint publications

Daniel Wang

1 joint publications

Bora Lim

1 joint publications

Amanda Rosewell Shaw

1 joint publications

Ya Xu

1 joint publications

Greyson G W Biegert

1 joint publications

Tao Wang

1 joint publications

Helen Heslop

1 joint publications

Malcolm K Brenner

Frequent Collaborators

3 joint publications

Masataka Suzuki

2 joint publications

Mae Woods

1 joint publications

Daniel Wang

1 joint publications

Bora Lim

Top Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on : Jan 07, 2019

Using the Chicken Chorioallantoic Membrane In Vivo Model to Study Gynecological and Urological Cancers

Using the Chicken Chorioallantoic Membrane In Vivo Model to Study Gynecological and Urological Cancers

Published on : Jan 28, 2020

See more related videos

Top Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on : Jan 07, 2019

Using the Chicken Chorioallantoic Membrane In Vivo Model to Study Gynecological and Urological Cancers

Using the Chicken Chorioallantoic Membrane In Vivo Model to Study Gynecological and Urological Cancers

Published on : Jan 28, 2020

See more related videos